4 ms·
Moderna cancer vaccine reduces melanoma’s return by 44%
- THENATHE 4y agoMy dad died of melanoma metastasis not but 2 months ago. He always joked he would be the last guy to die of cancer, and while I am sure we missed that mark, the sentiment of “if he just held out for a year or two more he woulda made it” is quite strong now. I’ve seen a treatment for his specific cancer that is like 4x as effective, now this, all since he passed. Wild to think about for sure
- mythhouse 4y agoreally interested in reading this if anyone have a non-paywall link.
- runnerup 4y agoSame. Archive and 12ft both fail.
- stubish 4y agohttps://investors.modernatx.com/news/news-details/2022/Moderna-and-Merck-Announce-mRNA-4157V940-an-Investigational-Personalized-mRNA-Cancer-Vaccine-in-Combination-with-KEYTRUDAR-pembrolizumab-Met-Primary-Efficacy-Endpoint-in-Phase-2b-KEYNOTE-942-Trial/default.aspx https://investors.modernatx.com/news/news-details/2022/Moder...
- adamredwoods 4y agoHere's the clinical trial: https://www.cancer.gov/about-cancer/treatment/clinical-trials/search/v?id=NCI-2019-04957 https://www.cancer.gov/about-cancer/treatment/clinical-trial... Here's the press release: https://investors.modernatx.com/news/news-details/2022/Moderna-and-Merck-Announce-mRNA-4157V940-an-Investigational-Personalized-mRNA-Cancer-Vaccine-in-Combination-with-KEYTRUDAR-pembrolizumab-Met-Primary-Efficacy-Endpoint-in-Phase-2b-KEYNOTE-942-Trial/default.aspx https://investors.modernatx.com/news/news-details/2022/Moder... Really impressive, as the study is 44% compared with pembrolizumab, which is not bad by itself either! Even more impressive is that it's two big companies working TOGETHER, and have an agreement to split profits!